As the Center for Medicare and Medicaid Innovation moves forward with additional drug-focused models, our Part D Senior ...

This lesson is part of our Searching for Justice series on criminal justice reform. For a Google doc version of this lesson, click here. (You will need to make a copy of the document to edit it.) ...

Across most markets in our economy consumers can easily obtain and process information regarding products for sale. So when, for instance, Ford launches the latest version of the F-150, based on ...

Texas District Court Judge Matthew Kacsmaryk’s decision Friday to rescind the approval of the abortion pill mifepristone dealt a blow to more than just people seeking a medication abortion. It appears ...

Peter Neumann ([email protected]) is director of the Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies at Tufts–New England Medical ...

Whoever says the Food and Drug Administration is too cozy with Big Pharma isn’t paying attention to the bonanza of new treatments launched by biotech startups. Late last week the FDA approved ...

Maia Szalavitz (an occasional Reason contributor) on some of the policy lessons one might glean (link added) from the overdose death of Glee star Cory Monteith: [Monteith] did a second round of rehab… ...

It is often said that the pharmaceutical industry only adapts in response to a crisis, and Vioxx might instigate the most dramatic of all changes. The withdrawal of Vioxx has exposed many scientific, ...

ALBANY – The state’s top court yesterday ruled that drug dealers can face harsher penalties for selling near schools, even if buildings separate the transactions from the educational facilities. State ...

Higger, 21, was interviewing Jesse, 29, as part of her Problem Solving Drug Courts class at F&M. She had prepared a list of questions, but quickly realized they were based on her life, not Jesse's. So ...